Innovative Approach to Vaccine Delivery via Mosquitoes
There’s a unique concept emerging from researchers regarding the coronavirus pandemic and the role mosquitoes may play as carriers or, well, “flying syringes.” It’s a bit of a wild idea, but some scientists have been looking into how mosquitoes could be used to deliver vaccines directly to humans.
Interestingly, a team from Leiden University Medical Center in the Netherlands, backed by the Bill Gates Foundation, has previously explored using these insects as a means of distributing vaccines. It seems they were onto something before this latest wave of interest.
Currently, scientists at the Chinese Academy of Sciences, in collaboration with the People’s Liberation Army Academy of Military Sciences, are investigating a method to target bats and simultaneously tackle mosquito populations. The idea is to develop vaccines based on the recombinant vesicular stomatitis virus, which could be effective against viruses like rabies and the Nipah virus.
The Nipah virus is indeed concerning, with a mortality rate potentially ranging from 40% to 75%. Rabies, on the other hand, is notorious for its almost total fatality rate once symptoms manifest. Bats, crucial to this discussion, represent about 22% of all mammalian species. They carry numerous zoonotic viruses without showing symptoms themselves, which contributes significantly to the emergence of infectious diseases.
The researchers suggest that vaccinating wild bats could curtail the spread of these viruses not only to humans but also to other animals. Yet, they acknowledge the challenges posed, such as the vast geographic spread, diverse diets, and large colonies of bats.
Interestingly, culling bats has been deemed impractical and potentially counterproductive. Instead, the team has focused on developing a vaccine that uses a weakened version of the vesicular stomatitis virus, which affects both insects and mammals.
They tested this approach by administering vaccine-laden blood to lab-adapted animals. The vaccine was detectable in both the mosquitoes and their salivary glands within two weeks, and these vaccinated mosquitoes seemed to effectively deliver the vaccine, providing some immune response in the test bats and rodents.
The study claims this innovative approach could be a scalable and efficient solution to the challenges of wild bat vaccination and disease control. Researchers are hopeful this could help in reducing the transmission of Nipah and rabies viruses from bats to humans and livestock.
Zheng Aihua, a Chinese virologist involved in the research, expressed optimism to NPR, stating that vaccinating populations could significantly lower or even eliminate virus transmission. However, there’s still a degree of uncertainty surrounding the effectiveness of these results. Concerns also linger about the implications of such a vaccination approach.
Daniel Streicher, a viral ecology professor not connected to the study, raised questions about the risks involved. He pointed out that mosquitoes bite not just bats but humans too, creating a pressing ethical dilemma regarding consent.
